247 related articles for article (PubMed ID: 23708211)
41. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
42. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
Hernando E; Charytonowicz E; Dudas ME; Menendez S; Matushansky I; Mills J; Socci ND; Behrendt N; Ma L; Maki RG; Pandolfi PP; Cordon-Cardo C
Nat Med; 2007 Jun; 13(6):748-53. PubMed ID: 17496901
[TBL] [Abstract][Full Text] [Related]
43. Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice.
Liu J; Muturi HT; Khuder SS; Helal RA; Ghadieh HE; Ramakrishnan SK; Kaw MK; Lester SG; Al-Khudhair A; Conran PB; Chin KV; Gatto-Weis C; Najjar SM
Metabolism; 2020 Jun; 107():154215. PubMed ID: 32209360
[TBL] [Abstract][Full Text] [Related]
44. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer.
Kim SJ; Lee HW; Baek JH; Cho YH; Kang HG; Jeong JS; Song J; Park HS; Chun KH
Oncogene; 2016 Jan; 35(2):251-60. PubMed ID: 25823029
[TBL] [Abstract][Full Text] [Related]
45. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
46. Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
Wang X; Su D; Qin Z; Chen Z
Gene; 2020 Jan; 722():144057. PubMed ID: 31430519
[TBL] [Abstract][Full Text] [Related]
47. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
48. Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas.
Wang CY; Wei Q; Han I; Sato S; Ghanbari-Azarnier R; Whetstone H; Poon R; Hu J; Zheng F; Zhang P; Wang W; Wunder JS; Alman BA
Cancer Res; 2012 Feb; 72(4):1013-22. PubMed ID: 22232736
[TBL] [Abstract][Full Text] [Related]
49. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
[TBL] [Abstract][Full Text] [Related]
50. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
51. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
[TBL] [Abstract][Full Text] [Related]
52. A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
Lee YF; John M; Falconer A; Edwards S; Clark J; Flohr P; Roe T; Wang R; Shipley J; Grimer RJ; Mangham DC; Thomas JM; Fisher C; Judson I; Cooper CS
Cancer Res; 2004 Oct; 64(20):7201-4. PubMed ID: 15492233
[TBL] [Abstract][Full Text] [Related]
53. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
54. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence.
Revandkar A; Perciato ML; Toso A; Alajati A; Chen J; Gerber H; Dimitrov M; Rinaldi A; Delaleu N; Pasquini E; D'Antuono R; Pinton S; Losa M; Gnetti L; Arribas A; Fraering P; Bertoni F; Nepveu A; Alimonti A
Nat Commun; 2016 Dec; 7():13719. PubMed ID: 27941799
[TBL] [Abstract][Full Text] [Related]
56. NOTCH and PTEN in prostate cancer.
Bertrand FE; McCubrey JA; Angus CW; Nutter JM; Sigounas G
Adv Biol Regul; 2014 Sep; 56():51-65. PubMed ID: 24933481
[TBL] [Abstract][Full Text] [Related]
57. Cooperation between liver-specific mutations of pten and tp53 genetically induces hepatocarcinogenesis in zebrafish.
Luo J; Lu C; Feng M; Dai L; Wang M; Qiu Y; Zheng H; Liu Y; Li L; Tang B; Xu C; Wang Y; Yang X
J Exp Clin Cancer Res; 2021 Aug; 40(1):262. PubMed ID: 34416907
[TBL] [Abstract][Full Text] [Related]
58. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
59. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
[TBL] [Abstract][Full Text] [Related]
60. CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.
Laroche-Clary A; Lucchesi C; Rey C; Verbeke S; Bourdon A; Chaire V; Algéo MP; Cousin S; Toulmonde M; Vélasco V; Shutzman J; Savina A; Le Loarer F; Italiano A
Ann Oncol; 2018 Apr; 29(4):1023-1029. PubMed ID: 29409053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
